Industry Day for FDA Contact Center Optimization
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, will host an Industry Day on Monday, February 23, 2026, focused on Contact Center Optimization. This Special Notice is for information gathering and planning purposes only and does not constitute a solicitation.
Purpose & Scope
The FDA is engaging industry partners to discuss its Contact Center Optimization Project. The Industry Day will provide a comprehensive overview of the project, its objectives, and goals. It is designed to help potential vendors understand the project's scope and allow the FDA to gather information from industry. The event will include general Q&A sessions and vendor networking opportunities.
Event Details
- Date: Monday, February 23, 2026
- Agenda: The preliminary agenda includes registration, welcome remarks, a project overview, discussion of objectives and goals, general Q&A, and vendor networking. Ground rules for Q&A will be provided.
- Location: Logistical details, including information regarding registration, venue, and final scheduling, will be posted to SAM.gov as they become available. The FDA's sub-tier is located in Silver Spring, MD.
- Nature: This Industry Day is strictly for planning and information-gathering. It does not represent a solicitation or a commitment by the Government. All information provided is for general guidance and does not amend or modify any official solicitation document.
Key Actions
Interested parties are strongly encouraged to monitor SAM.gov for future announcements and updates concerning this event, including registration and venue details. Content from the Q&A sessions may be incorporated into a Frequently Asked Questions (FAQ) document.
Contact Information
- Primary Contact: Lilibeth Deato (lilibeth.deato@fda.hhs.gov)
- Secondary Contact: Min Jie Zeng (minjie.zeng@fad.hhs.gov)